PT1554240E - Tetralinas e indanos substituídos e sua utilização - Google Patents

Tetralinas e indanos substituídos e sua utilização Download PDF

Info

Publication number
PT1554240E
PT1554240E PT03773302T PT03773302T PT1554240E PT 1554240 E PT1554240 E PT 1554240E PT 03773302 T PT03773302 T PT 03773302T PT 03773302 T PT03773302 T PT 03773302T PT 1554240 E PT1554240 E PT 1554240E
Authority
PT
Portugal
Prior art keywords
indanes
substituted tetralins
tetralins
substituted
tetralin
Prior art date
Application number
PT03773302T
Other languages
English (en)
Inventor
Jay M Matthews
Keith T Demarest
Xiaoli Chen
Jung Lee
Philip Rybczynski
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT1554240E publication Critical patent/PT1554240E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
PT03773302T 2002-10-21 2003-10-17 Tetralinas e indanos substituídos e sua utilização PT1554240E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42002602P 2002-10-21 2002-10-21
US49578803P 2003-08-15 2003-08-15

Publications (1)

Publication Number Publication Date
PT1554240E true PT1554240E (pt) 2009-06-17

Family

ID=32179777

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03773302T PT1554240E (pt) 2002-10-21 2003-10-17 Tetralinas e indanos substituídos e sua utilização

Country Status (28)

Country Link
US (2) US20040167211A1 (pt)
EP (1) EP1554240B1 (pt)
JP (1) JP4411275B2 (pt)
KR (1) KR100989394B1 (pt)
CN (1) CN100354259C (pt)
AT (1) ATE430728T1 (pt)
AU (1) AU2003279996B2 (pt)
BR (1) BR0315623A (pt)
CA (1) CA2502665A1 (pt)
CY (1) CY1110326T1 (pt)
DE (1) DE60327543D1 (pt)
DK (1) DK1554240T3 (pt)
EA (1) EA009554B1 (pt)
ES (1) ES2325783T3 (pt)
HR (1) HRP20050336B1 (pt)
IL (1) IL168147A (pt)
ME (1) MEP53108A (pt)
MX (1) MXPA05004192A (pt)
NO (1) NO332352B1 (pt)
NZ (1) NZ539451A (pt)
PL (1) PL376326A1 (pt)
PT (1) PT1554240E (pt)
RS (1) RS52079B (pt)
SI (1) SI1554240T1 (pt)
TW (1) TWI308563B (pt)
UA (1) UA80561C2 (pt)
WO (1) WO2004037779A1 (pt)
ZA (1) ZA200504064B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037778A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
JP2006503915A (ja) * 2002-10-21 2006-02-02 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換テトラリンおよびインダンを用いたx症候群の治療
AR048931A1 (es) * 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis
CN101076524A (zh) * 2004-10-12 2007-11-21 法马科皮亚药物研发公司 作为选择性黑色素浓集激素受体拮抗剂的治疗肥胖和相关病症的双环化合物
EP2991967A1 (en) * 2013-03-20 2016-03-09 F. Hoffmann-La Roche AG Urea derivatives and their use as fatty-acid binding protein (fabp) inhibitors

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
GB9027023D0 (en) 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
DE69422044T2 (de) 1993-08-06 2000-05-31 Upjohn Co 2-aminoindane als selektive dopamin-d3-liganden
GB9606805D0 (en) * 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
EP1666587A1 (en) 1996-06-13 2006-06-07 Astellas Pharma Inc. Cyclic lipopeptide acylase
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds
US6300339B1 (en) * 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
TWI234557B (en) 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
JP2003523336A (ja) * 2000-02-18 2003-08-05 メルク エンド カムパニー インコーポレーテッド 糖尿病及び脂質障害のためのアリールオキシ酢酸
EE200300140A (et) * 2000-10-05 2003-08-15 Bayer Aktiengesellschaft PPAR-alfat aktiveerivate omadustega propaanhappe derivaadid
JPWO2002044129A1 (ja) * 2000-11-29 2004-04-02 杏林製薬株式会社 置換カルボン酸誘導体
AU2002222573A1 (en) * 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
JP2004517100A (ja) * 2000-12-20 2004-06-10 グラクソ グループ リミテッド hPPARアルファアゴニストとしての置換オキサゾールおよびチアゾール
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
BR0207285A (pt) 2001-02-15 2004-02-10 Pfizer Producs Inc Agonistas de ppar
CA2438492A1 (en) 2001-02-15 2002-08-22 Pfizer Products Inc. Proliferative activator receptor (ppar) compounds
US6548538B2 (en) * 2001-05-22 2003-04-15 Bayer Aktiengesellschaft Propionic acid derivatives
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
WO2004037778A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
JP2006503915A (ja) * 2002-10-21 2006-02-02 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換テトラリンおよびインダンを用いたx症候群の治療
AR048931A1 (es) * 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis

Also Published As

Publication number Publication date
BR0315623A (pt) 2005-08-23
JP2006503917A (ja) 2006-02-02
CA2502665A1 (en) 2004-05-06
RS20050320A (en) 2007-11-15
CN1726187A (zh) 2006-01-25
NO20052280L (no) 2005-06-24
TWI308563B (en) 2009-04-11
PL376326A1 (en) 2005-12-27
TW200418774A (en) 2004-10-01
HRP20050336B1 (hr) 2013-06-30
JP4411275B2 (ja) 2010-02-10
CY1110326T1 (el) 2015-01-14
US20060074130A1 (en) 2006-04-06
ES2325783T3 (es) 2009-09-17
WO2004037779A1 (en) 2004-05-06
SI1554240T1 (sl) 2009-10-31
EA009554B1 (ru) 2008-02-28
DK1554240T3 (da) 2009-08-17
AU2003279996B2 (en) 2009-07-09
NZ539451A (en) 2008-03-28
NO332352B1 (no) 2012-09-03
KR20050071597A (ko) 2005-07-07
US7351857B2 (en) 2008-04-01
KR100989394B1 (ko) 2010-10-25
RS52079B (sr) 2012-06-30
AU2003279996A1 (en) 2004-05-13
DE60327543D1 (de) 2009-06-18
CN100354259C (zh) 2007-12-12
US20040167211A1 (en) 2004-08-26
EP1554240A1 (en) 2005-07-20
UA80561C2 (en) 2007-10-10
MEP53108A (en) 2011-05-10
MXPA05004192A (es) 2005-09-20
ATE430728T1 (de) 2009-05-15
IL168147A (en) 2010-11-30
HRP20050336A2 (en) 2006-11-30
ZA200504064B (en) 2006-09-27
EA200500516A1 (ru) 2005-10-27
EP1554240B1 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
IL168147A (en) Substituted tetralins and indanes and their use
NO20052277L (no) Behandling av syndrom X med substituerte tetraliner og indaner
GEP20074197B (en) 5ht2c receptor modulators
TW200740799A (en) Alpha2C adrenoreceptor agonists
MXPA04006280A (es) Compuestos espiroazaciclicos como moduladores de receptor de monoamina.
MY147518A (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
SG145752A1 (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
TW200724140A (en) Hydantoin compounds
MXPA04004745A (es) Agonista de receptor de dopamina-d2 parcial y actividad inhibidora de serotonina y/o noradrenalina.
MY145712A (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
NO20052199L (no) Substituerte tetraliner og indaner
ATE433458T1 (de) Modulatoren von ship-1
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
SG149041A1 (en) 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MX2010004422A (es) Compuestos de 2,3-dihidro-benzofurano.
UA85198C2 (ru) Производные морфолина как ингибиторы повторного поглощения норэпинефрина
ECSP003458A (es) Compuestos para tratar la obesidad
TW200504016A (en) Inhibitors of monoamine uptake
MX2010004469A (es) Compuestos de fenilpirrolidina.
ECSP066623A (es) Bencimidazol-, benztriazol-, y bencimidazolona-o-glucosidos sustituidos